Abstract
β-Glucan is linear polysaccharides containing d-glucose monomers connected by β-glycosidic linkages. Their structural variances are the result of several sources. This research project was designed to assess the anticancer activity by using β-glucan. The in vitro experiment employed breast cancer cell lines from Michigan Cancer Foundation-7 (MCF-7) and Ahmed, Murtudha, Jabriyah, 2013 (AMJ13). After 24, 48, and 72 hours in micro titration plate under completely sterile condition. Different concentrations of β-glucan (31.25, 62.5, 125, 250, 500, and 1000 μg/mL) were applied to the cancer cell lines. The MTT assay was used to check whether the cells had been inhibited. Cell viability in MCF7 and AMJ13 cells was significantly reduced by β-glucan. β-Glucan showed concentration and time-dependent growth inhibitory effects. The higher concentrations of β-glucan significantly (P<0.05) decrease the growth rate of cells, indicating that the higher concentrations were more effective at inhibiting growth.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
